Influence of HLA-DRB1 alleles on lymphoproliferative responses to a naturally processed and presented measles virus phosphoprotein in measles immunized individuals

Human Immunology

Volumn 65, Issue 3, 2004, Pages 209-217

  Ovsyannikova, Inna G ^a   Poland, Gregory A ^a   Easler, Nathan J ^a   Vierkant, Robert A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cellular immunity; HLA class II epitopes; Measles; Measles peptides; T cell recognition

Indexed keywords

ALANYLSERYLASPARTYLVALYLGLUTAMYLTHREONYLALANYLGLUTAMYLGLYCYLGLYCYLGLUTAMYLI SOLEUCYLHISTIDYLGLUTAMYLLEUCYLLEUCYLARGINYLLEUCYLGLUTAMINE; GLUTAMIC ACID; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; MEASLES VACCINE; PEPTIDE; PHOSPHOPEPTIDE; PROLYLLEUCYLARGINYLHISTIDYLGLUTAMINYLALANYLTHREONYLTHREONYLALANYLSERYLSERYL THREONYLLYSYLPROLINE; THREONYLALANYLGLUTAMYLGLYCYLGLYCYLGLUTAMYLISOLEUCYLHISTIDYLLYSYLLEUCYLLEUCY LARGINYLLEUCYLGLUTAMINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGEN RECOGNITION; ARTICLE; BLOOD SAMPLING; CELLULAR IMMUNITY; CONTROLLED STUDY; GENE FREQUENCY; HUMAN; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MEASLES VACCINATION; MEASLES VIRUS; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SCHOOL CHILD; SEQUENCE ANALYSIS; T LYMPHOCYTE;

ALLELES; AMINO ACID SUBSTITUTION; ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; EPITOPES, T-LYMPHOCYTE; HLA-DR ANTIGENS; HUMANS; MEASLES VACCINE; MEASLES VIRUS; PHOSPHOPROTEINS;

EID: 1642406138     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2003.12.002     Document Type: Article

References (33)

1. Carrington M., O'Brien S.J. The influence of HLA genotype on AIDS. Annu Rev Med. 54:2003;535.
2. Gans H.A., Maldonado Y., Yasukawa L.L., Beeler J., Audet S., Rinki M.M., DeHovitz R., Arvin A.M. IL-12, IFNγ, and T cell proliferation to measles in immunized infants. J Immunol. 162:1999;5569.
3. Poland G.A. Immunogenetic mechanisms of antibody response to measles vaccine: the role of the HLA genes. Vaccine. 17:1999;1719.
4. Jacobson R.M., Poland G.A., Vierkant R.A., Pankratz V.S., Schaid D.J., Jacobsen S.J., St. Sauver J.L., Moore S.B. The association of class I HLA alleles and antibody levels following a single dose of measles vaccine. Hum Immunol. 64:2003;103.
5. Poland G.A., Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Jacobsen S.J., Pankratz V.S., Schaid D.J. Identification of an association between HLA class II alleles and low antibody levels after measles immunization. Vaccine. 20:2001;430.
6. Ovsyannikova I.G., Johnson K.L., Naylor S., Muddiman D.C., Poland G.A. Naturally processed measles virus peptide eluted from class II HLA-DRB1 *03 recognized by T lymphocytes from human blood. Virology. 312:2003;495.
7. + class MHC-restricted cytotoxic T lymphocytes (CTL) in recovery from measles. J Immunol. 144:1990;2394.
8. Griffin D.E., Ward B.J. Differential CD4 T cell activation in measles. J Infect Dis. 168:1993;275.
9. van Els C.A.C.M., Nanan R. T cell responses in acute measles. Viral Immunol. 15:2002;435.
10. Herberts C.A., Stittelaar K.J., van der H.E., van Gaans-Van den Brink J., Poelen M.C.M., Roholl P.J.M., van Alphen L.J.W., Melief C.J.M., de Jong A.P.J.M., van Els C.A.C.M. A measles virus glycoprotein-derived human CTL epitope is abundantly presented via the proteasomal-dependent MHC class I processing pathway. J Gen Virol. 82:2001;2131.
11. van Els C.A.C.M., Herberts C.A., van der Heeft E., Poelen M.C.M., van Gaans-van den Brink J.A.M., van der Kooi A., Hoogerhout P., ten Hove G.J., Meiring H.D., de Jong A.P.J.M. A single naturally processed measles virus peptide fully dominates the HLA-A*00201-associated peptide display and is mutated at its anchor position inpersistent viral strains. Eur J Immunol. 30:2000;1172.
12. Herberts C.A., Meiring H.M., van Gaans-van den Brink J.A.M., van der Heeft E., Poelen M.C.M., Boog C.J.P., de Jong A.P.J.M., van Els C.A.C.M. Dynamics of measles virus protein expression are reflected in the MHC class I epitope display. Mol Immunol. 39:2003;567.
13. Ward B.J., Boulianne N., Ratnam S., Guiot M.-C., Couillard M., De Serres G. Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination. J Infect Dis. 172:1995;1591.
14. Gallagher M.R., Welliver R., Yamanaka T., Eisenberg B., Sun M., Ogra P.L. Cell-mediated immunity responsiveness to measles. Am J Dis Child. 135:1981;48.
15. Gans H.A., Arvin A.M., Galinus J., Logan L., DeHovitz R., Maldonado Y. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA. 280:1998;527.
16. Pabst H.F., Spady D.W., Carson M.M., Krezolek M.P., Barreto L., Wittes R.C. Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6 month old infants. Vaccine. 17:1999;1910.
17. Ovsyannikova IG, Johnson KL, Muddiman DC, Vierkant RA, Poland GA: Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides. J Virol, 78:2, 2004.
18. Büchler T., Gallardo D., Rodríguez-Luaces M., Pujal J.M., Granena A. Frequency of HLA-DPB1 disparities detected by reference strand-mediated conformation analysis in HLA-A, -B, and -DRB1 matched siblings. Hum Immunol. 63:2002;139.
19. + T cells in subjects seronegative or highly seropositive for measles vaccine. Clin Diag Lab Immunol. 10:2003;411.
20. + cytotoxic T cell clones. J Immunol. 142:1989;2847.
21. Doolan D.L., Southwood S., Chesnut R., Appella E., Gomez E., Richards A., Higashimoto Y.I., Maewal A., Sidney J., Gramzinski R.A., Mason C., Koech D., Hoffman S.L., Sette A. HLA-DR promiscuous T cell epitopes from Plasmodium falciparum ore-erythrocytic-state antigens restricted by multiple HLA class II alleles. J Immunol. 165:2000;1123.
22. Pauksen K., Sjolin J., Linde A., Alm G., Andersson B., Lonnerholm G., Ljungman P. Th1 and Th2 cytokine responses after measles antigen stimulation in vitro in bone marrow transplant patients: response to measles vaccination. Bone Marrow Transplant. 20:1997;317.
23. Hickman C.J., Khan A.S., Rota P.A., Bellini W.J. Use of synthetic peptides to identify measles nucleoprotein T-cell epitopes in vaccinated and naturally infected humans. Virology. 235:1997;386.
24. van Binnendijk R.S., Versteeg-van Oosten J.P.M., Poelen M.C.M., Brugghe H.F., Hoogerhout P., Osterhaus A.D.M.E., Uytdehaag F.G.C.M. Human HLA class I- and HLA class II-restricted cloned cytotoxic T lymphocytes identify a cluster of epitopes on the measles virus fusion protein. J Virol. 67:1993;2276.
25. + memory T cells in measles-seropositive individuals by in vitro peptide stimulation. Clin Exp Immunol. 102:1995;40.
26. Jaye A., Herberts C.A., Jallow S., Atabani S., Klein M.R., Hoogerhout P., Kidd M., van Els C.A., Whittle H.C. Vigorous but short-term gamma interferon T-cell responses against a dominant HLA-A*02-restricted measles virus epitope in patients with measles. J Virol. 77:2003;5014.
27. Southwood S., Sidney J., Kondo A., del Guercio M.F., Appella E., Hoffman S., Kubo R.T., Chesnut R.W., Grey H.M., Sette A. Several common HLA-DR types share largely overlapping peptide binding repertoires. J Immunol. 160:1998;3363.
28. Wang J.H., Layden T.J., Eckels D.D. Modulation of the peripheral T-cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response. Hum Immunol. 64:2003;662.
29. Lodish H., Baltimore D., Berk A., Zipursky S.L., Matsudaira P., Darnell J. Protein structure and function. Lodish H., Baltimore D., Berk A., Zipursky S.L., Matsudaira P., Darnell J. Molecular Cell Biology. 1995;Scientific American Books, W. H. Freeman and Company, New York.
30. St. Sauver J.L., Schaid D.J., Vierkant R.A., Jacobson R.M., Jacobsen S.J., Ovsyannikova I.G., Poland G.A. Associations between measles antibody levels and the protein structure of class II human leukocyte antigens. Hum Immunol. 64:2003;696.
31. Desombere I., Hauser P., Rossau R., Paradijs J., Leroux-Roels G. Nonresponders to hepatitis B vaccine can present envelope particles to T lymphocytes. J Immunol. 154:1995;520.
32. Craven D.E., Awdeh Z.L., Kunches L.M., Yunis E.J., Dienstag J.L., Werner B.G., Polk B.F., Snydman D.R., Platt R., Crumpacker C.S., Grady G.F., Alper C.A. Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic tyings. Ann Intern Med. 105:1986;356.
33. Almarri A., Batchelor J.R. HLA and hepatitis B infection. Lancet. 344:1994;1194.